Cargando…
ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by poor response to standard therapies and therefore unfavorable clinical outcomes. Better understanding of TNBC and new therapeutic strategies are urgently needed. ROR nuclear receptors are multifunctional transcription f...
Autores principales: | Kim, Eunju, Kim, Yoon-Jin, Ji, Zhiwei, Kang, Jin Muk, Wirianto, Marvin, Paudel, Keshav Raj, Smith, Joshua A., Ono, Kaori, Kim, Jin-Ah, Eckel-Mahan, Kristin, Zhou, Xiaobo, Lee, Hyun Kyoung, Yoo, Ji Young, Yoo, Seung-Hee, Chen, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018867/ https://www.ncbi.nlm.nih.gov/pubmed/35440077 http://dx.doi.org/10.1038/s41419-022-04826-5 |
Ejemplares similares
-
The Circadian Nobiletin-ROR Axis Suppresses Adipogenic Differentiation and IκBα/NF-κB Signaling in Adipocytes
por: Kim, Eunju, et al.
Publicado: (2023) -
Effects of the Clock Modulator Nobiletin on Circadian Rhythms and Pathophysiology in Female Mice of an Alzheimer’s Disease Model
por: Kim, Eunju, et al.
Publicado: (2021) -
The clock modulator Nobiletin mitigates astrogliosis‐associated neuroinflammation and disease hallmarks in an Alzheimer’s disease model
por: Wirianto, Marvin, et al.
Publicado: (2022) -
Nobiletin, a NF‐κB signaling antagonist, promotes BMP‐induced bone formation
por: Rojasawasthien, Thira, et al.
Publicado: (2022) -
Nobiletin alleviates endometriosis via down-regulating NF-κB activity in endometriosis mouse model
por: Wei, Xin, et al.
Publicado: (2018)